Intranasal Ablation — CPB 0592 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0592 covering intranasal ablation, effective September 26, 2025. CPT 30801 and 30802 remain covered for turbinate reduction tied to chronic nasal obstruction — but snoring alone won't get you paid, and CPT 31242 and 31243 are explicitly not covered under this policy.

Aetna Intranasal Ablation Coverage Policy: What This Modification Means in 2025

The Aetna intranasal ablation coverage policy under CPB 0592 draws a hard line between two clinical scenarios your ENT and sleep medicine billers deal with every day. Chronic nasal obstruction from mucosal hypertrophy of the inferior turbinates — covered. Snoring — not covered, full stop.

That distinction sounds simple. In practice, it's where claims fall apart. Patients presenting for turbinate reduction often carry a snoring complaint alongside a legitimate structural diagnosis. If your diagnosis coding leans on R06.83 (snoring) instead of J34.3 (hypertrophy of nasal turbinates) or the appropriate J34-range codes, Aetna will deny the claim. The medical necessity criteria are narrow and the payer enforces them.

The modification effective September 26, 2025 doesn't change the fundamental coverage logic — RFVTR (radiofrequency volumetric tissue reduction, also marketed as Somnoplasty) stays medically necessary for turbinate hypertrophy causing nasal obstruction. What your billing team needs to do right now is make sure your charge capture and documentation practices reflect the distinction the policy is making.

Aetna Intranasal Ablation Coverage Criteria and Medical Necessity Requirements 2025

Aetna considers radiofrequency volumetric tissue reduction of the inferior turbinates medically necessary when the clinical picture is chronic nasal obstruction caused by mucosal hypertrophy of the inferior turbinates. That's the covered indication. It maps to CPT 30802 (intramural RFVTR or Somnoplasty) and the broader turbinate ablation code CPT 30801.

Medical necessity requires the right diagnosis on the claim. ICD-10 J34.3 (hypertrophy of nasal turbinates) is your primary target code for the covered indication. The J34.0–J34.9 range covering other specified disorders of the nose and nasal sinuses also appears in the policy, along with J31.0 for chronic rhinitis (including rhinitis medicamentosa) and the allergic rhinitis codes J30.1 through J30.9.

Allergic rhinitis driving inferior turbinate hypertrophy is a legitimate clinical path to coverage. Document the chain: allergic or chronic rhinitis causing turbinate enlargement causing nasal obstruction. If your physician's notes support that chain, your billing should reflect it with the right ICD-10 pairing.

Prior authorization requirements for CPT 30801 and 30802 vary by Aetna plan. Check the member's specific plan benefits before scheduling. Don't assume commercial Aetna plans align with Aetna Medicare Advantage on prior auth — they often don't. If you're billing across multiple Aetna product lines, verify prior authorization requirements plan by plan.

This coverage policy does not mention reimbursement rates. Those are set by your contracted fee schedule with Aetna and don't change with a CPB modification. But claim denial rates will shift if your documentation doesn't match the tightened criteria — which is the real financial exposure here.

Aetna Intranasal Ablation Exclusions and Non-Covered Indications

Snoring as a standalone indication gets you nowhere under this policy. Aetna explicitly considers RFVTR of turbinates for snoring not medically necessary. If the referring diagnosis is R06.83 and nothing else supports structural nasal obstruction, the claim will not pay.

This matters because G47.33 (obstructive sleep apnea) is listed in the policy's ICD-10 code set — but its presence doesn't automatically justify turbinate ablation for an Aetna member. Sleep apnea patients who also have inferior turbinate hypertrophy causing nasal obstruction may qualify. But sleep apnea alone, or snoring alone, isn't the covered indication. Your physician documentation needs to establish the turbinate pathology independently.

CPT 31242 and 31243 are explicitly not covered under this policy for any of the listed indications. Those are the endoscopic surgical codes for posterior nasal nerve destruction — by radiofrequency ablation (31242) and cryoablation (31243). If your ENT team has started billing those codes for nasal obstruction or rhinitis, stop. Aetna won't pay them under CPB 0592, and billing them anyway creates claim denial risk and potential compliance exposure.

CPT 30117 — excision or destruction of an intranasal lesion via internal approach — is similarly flagged as not covered for the indications listed in this policy. That code is a different clinical scenario, but if it's appearing on turbinate-related claims in error, it needs to come off.

Coverage Indications at a Glance

Aetna Intranasal Ablation Billing Guidelines and Action Items 2025

The effective date of September 26, 2025 is your deadline. Any claim for CPT 30801 or 30802 submitted for dates of service on or after that date needs to reflect what this policy says. Here's what to do now.

If your practice has high Aetna volume in ENT or sleep medicine, loop in your compliance officer before the September 26 effective date. The snoring exclusion is where audit risk concentrates — especially for practices that treat a lot of sleep apnea patients who also present with nasal obstruction.

CPT, HCPCS, and ICD-10 Codes for Intranasal Ablation Under CPB 0592

Covered CPT Codes (When Selection Criteria Are Met)

Not Covered CPT Codes

Key ICD-10-CM Diagnosis Codes